Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. ARS Pharmaceuticals Inc shares valued at $1,140,295 were sold by Tanimoto Sarina on Jul 16 ’24. At $11.40 per share, Tanimoto Sarina sold 100,000 shares. The insider’s holdings dropped to 1,547,447 shares worth approximately $16.23 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Lowenthal Richard E sold 100,000 shares, netting a total of over 1,140,295 in proceeds. Following the sale of shares at $11.40 each, the insider now holds 1,547,447 shares.
Before that, Tanimoto Sarina had sold 100,000 shares from its account. In a trade valued at $961,725, the CHIEF MEDICAL OFFICER traded ARS Pharmaceuticals Inc shares for $9.62 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $15.7 million.
As published in their initiating research note from Raymond James on July 25, 2024, ARS Pharmaceuticals Inc [SPRY] has been an Outperform and the price target has been revised to $18. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in early March. As of February 20, 2024, William Blair has increased its “Mkt perform” rating to a “an Outperform” for SPRY. Earlier on September 20, 2023, William Blair downgraded its rating. Their new recommendation was “a Mkt perform” for SPRY stock which previously was a “an Outperform”.
Analyzing SPRY Stock Performance
During the last five days, there has been a drop of approximately -6.26%. Over the course of the year, ARS Pharmaceuticals Inc shares have jumped approximately 91.42%. Shares of the company reached a 52-week high of $11.90 on 07/15/24 and a 52-week low of $5.19 on 01/04/24. A 50-day SMA is recorded $9.47, while a 200-day SMA reached $7.45. Nevertheless, trading volume fell to 0.6 million shares from 0.39 million shares the previous day.
Support And Resistance Levels for ARS Pharmaceuticals Inc (SPRY)
According to the 24-hour chart, there is a support level at 10.07, which, if violated, would cause prices to drop to 9.64. In the upper region, resistance lies at 10.98. The next price resistance is at 11.46. RSI (Relative Strength Index) is 53.21 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.10, which suggests the price will decrease in the coming days. Percent R is at 77.47%, indicating bearish price movement. Stochastics%K at holding indicates that the stock is to be held.
